Advertisement
U.S. markets open in 3 hours 43 minutes
  • S&P Futures

    5,206.50
    -8.25 (-0.16%)
     
  • Dow Futures

    39,177.00
    -46.00 (-0.12%)
     
  • Nasdaq Futures

    18,196.00
    -35.50 (-0.19%)
     
  • Russell 2000 Futures

    2,043.30
    -6.50 (-0.32%)
     
  • Crude Oil

    82.44
    -0.28 (-0.34%)
     
  • Gold

    2,156.20
    -8.10 (-0.37%)
     
  • Silver

    25.11
    -0.15 (-0.59%)
     
  • EUR/USD

    1.0845
    -0.0032 (-0.29%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.54
    +0.21 (+1.47%)
     
  • GBP/USD

    1.2674
    -0.0055 (-0.43%)
     
  • USD/JPY

    150.6220
    +1.5240 (+1.02%)
     
  • Bitcoin USD

    63,520.79
    -4,489.20 (-6.60%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,719.39
    -3.16 (-0.04%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Costa Rica signs COVID-19 vaccine deal with Pfizer and BioNTech

SAN JOSE, Dec 3 (Reuters) - Costa Rica has signed an agreement with pharmaceutical companies Pfizer Inc and its German partner BioNTech SE for the manufacture and delivery of 3 million COVID-19 vaccines next year, the office of President Carlos Alvarado said on Thursday.

Deliveries will be made throughout the four quarters of 2021, as established in an initial agreement announced on Oct. 1, the president's office said in a statement.

The deal will allow Costa Rica to provide two doses to 1.5 million people and follows accords with AstraZeneca and the Covax mechanism backed by the World Health Organization. In total, the agreements should cover about 3 million people, or almost 60% of the Costa Rican population.

The Central American country has so far registered some 142,505 cases of coronavirus and 1,757 related deaths. (Reporting by Alvaro Murillo; Editing by Leslie Adler)

Advertisement